Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FV6B1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,630
Award facts
- Contract value 100% obligated
- $15,629.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,629.67 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on November 13, 2025, with an ultimate completion date of November 14, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound, a glucagon-like peptide-1 (GLP-1) receptor agonist used for weight management, represents part of the broader pharmaceutical supply chain supporting Department of Defense medical needs.
This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen maintains a comprehensive federal contract portfolio supplying medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare systems and other federal medical programs. The company's selection reflects its demonstrated capability to fulfill federal procurement requirements through competitive processes and its established role as a critical vendor within the Defense Logistics Agency's pharmaceutical supply infrastructure.
Quick answers
Who was awarded contract SPE2DR26FV6B1?
SPE2DR26FV6B1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FV6B1 worth?
The government has obligated $15,630 on SPE2DR26FV6B1.
Is contract SPE2DR26FV6B1 an order under another contract?
Yes. SPE2DR26FV6B1 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV6B1 competed?
The extent of competition for SPE2DR26FV6B1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award